Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hammond

Showing results (511-520 of 711) with videos related to

Pageof 72
Sort By:
Immunogenetics|February 10, 2017
The evolution of the natural killer complex; a comparison between mammals using new high-quality genome assemblies and targeted annotationJohn C Schwartz, Mark S Gibson, Dorothea Heimeier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI-774 in human epidermis of cancer patientsShazli N Malik, Lillian L Siu, Eric K Rowinsky, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Strictly target cell-dependent activation of T cells by bispecific single-chain antibody constructs of the BiTE classKlaus Brischwein, Larissa Parr, Stefan Pflanz, et al.
Cancer Research|April 19, 2007
Selective targeting and potent control of tumor growth using an EphA2/CD3-Bispecific single-chain antibody constructScott A Hammond, Ralf Lutterbuese, Shannon Roff, et al.
Proceedings. Biological Sciences|October 24, 2014
Evidence for a genetic basis of urogenital carcinoma in the wild California sea lionHelen M Browning, Karina Acevedo-Whitehouse, Frances M D Gulland, et al.
The International Journal of Behavioral Nutrition and Physical Activity|May 9, 2024
Uncovering physical activity trade-offs in transportation policy: A spatial agent-based model of Bogotá, ColombiaIvana Stankov, Jose D Meisel, Olga Lucia Sarmiento, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1991
Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cellsS A Hammond, E Obah, P Stanhope, et al.
American Journal of Human Genetics|December 1, 1991
Linkage of the gene for an X-linked mental retardation disorder to a hypervariable (AGAT)n repeat motif within the human hypoxanthine phosphoribosyltransferase (HPRT) locus (Xq26)T H Huang, J F Hejtmancik, A Edwards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
A phase I and pharmacokinetic study of Col-3 (Metastat), an oral tetracycline derivative with potent matrix metalloproteinase and antitumor propertiesSamira Syed, Chris Takimoto, Manuel Hidalgo, et al.
Immunogenetics|July 21, 2018
IPD-MHC: nomenclature requirements for the non-human major histocompatibility complex in the next-generation sequencing eraGiuseppe Maccari, James Robinson, Ronald E Bontrop, et al.
Pageof 72

Showing results (511-520 of 711) with videos related to

Sort By:
Pageof 72
Immunogenetics|February 10, 2017
The evolution of the natural killer complex; a comparison between mammals using new high-quality genome assemblies and targeted annotationJohn C Schwartz, Mark S Gibson, Dorothea Heimeier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI-774 in human epidermis of cancer patientsShazli N Malik, Lillian L Siu, Eric K Rowinsky, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Strictly target cell-dependent activation of T cells by bispecific single-chain antibody constructs of the BiTE classKlaus Brischwein, Larissa Parr, Stefan Pflanz, et al.
Cancer Research|April 19, 2007
Selective targeting and potent control of tumor growth using an EphA2/CD3-Bispecific single-chain antibody constructScott A Hammond, Ralf Lutterbuese, Shannon Roff, et al.
Proceedings. Biological Sciences|October 24, 2014
Evidence for a genetic basis of urogenital carcinoma in the wild California sea lionHelen M Browning, Karina Acevedo-Whitehouse, Frances M D Gulland, et al.
The International Journal of Behavioral Nutrition and Physical Activity|May 9, 2024
Uncovering physical activity trade-offs in transportation policy: A spatial agent-based model of Bogotá, ColombiaIvana Stankov, Jose D Meisel, Olga Lucia Sarmiento, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1991
Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cellsS A Hammond, E Obah, P Stanhope, et al.
American Journal of Human Genetics|December 1, 1991
Linkage of the gene for an X-linked mental retardation disorder to a hypervariable (AGAT)n repeat motif within the human hypoxanthine phosphoribosyltransferase (HPRT) locus (Xq26)T H Huang, J F Hejtmancik, A Edwards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
A phase I and pharmacokinetic study of Col-3 (Metastat), an oral tetracycline derivative with potent matrix metalloproteinase and antitumor propertiesSamira Syed, Chris Takimoto, Manuel Hidalgo, et al.
Immunogenetics|July 21, 2018
IPD-MHC: nomenclature requirements for the non-human major histocompatibility complex in the next-generation sequencing eraGiuseppe Maccari, James Robinson, Ronald E Bontrop, et al.
Pageof 72